← Back to Clinical Trials
Recruiting NCT02134574
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Trial Parameters
Condition Hematologic Malignancy
Sponsor University Hospital, Montpellier
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-02
Completion 2033-06
Interventions
hematologic malignancy
Brief Summary
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
Eligibility Criteria
Inclusion criteria: * Age over 18 * Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent * Having signed an informed consent * Affiliated with a social security scheme Exclusion criteria: * Minor or major protected * Patients who have received treatment for hematological pathology